Keywords: bayer/onyx, submit, snda, nexavar, hcc, german, drug

Bayer/Onyx submit US sNDA for Nexavar in HCC

Article | 02 July 2007

Print This

German drug major Bayer and the USA's Onyx Pharmaceuticals have submitted a supplemental New Drug Application for Nexavar (sorafenib) tablets ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in